Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Retatrutide Dosage Based on Clinical Studies: The Scientific Foundation Dosing guidelines for retatrutide are based on the Phase 2 data published by Jastreboff and colleagues in NEJM (2023) and, as of 2026, on the first Phase 3 data from TRIUMPH-4
BPC-157 affects nerve regeneration and neuropathy by stimulating axonal regrowth, improving nerve conduction velocity, and protecting neurons from further damage through angiogenic and anti-inflammatory activity
Reconstituted BPC-157 should be refrigerated and used within the suppliers stated window, typically a few weeks
TB-500 has been characterised as reducing inflammatory cytokine production, modulating macrophage polarisation toward pro-repair phenotypes, and attenuating the fibrotic deposition that can impair functional tissue repair when the inflammatory phase is prolonged or dysregulated
DrugBank Online - BPC-157 Clinical Trials: Lists one Phase 1 trial (NCT02637284) for healthy volunteers
US$ 24.57
US$ 23.61
US$ 23.70
US$ 27.13
